Home / News
-
OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies
-
OncoHost will use SomaLogic's SomaScan platform to develop proteomic tests for OncoHost's Prophet diagnostic system to predict patient response to immunotherapy treatments and develop strategies to overcome treatment resistance, the two firms announced on Monday.2022-06-14View More
-
-
Because of the COVID-19 epidemic, the IVD industry has developed rapidly in the past two years, a large amount of capital and talents have poured in. However, with the normalization of epidemic prevention and control, the IVD industry is also returning to the original normal track.2022-06-13View More
-
-
People in the News at Quest Diagnostics, Molecular Assemblies, Informed DNA, More. Quest Diagnostics has named Sam Samad executive vice president and CFO2022-06-13View More
-
-
ASMS Product Launches: Thermo Fisher, Bruker, Waters, Shimadzu, Newomics2022-06-13View More
-
-
On June 8, Singlera Genomics (Shanghai) Ltd. (hereinafter referred to as ¡°Singlera Genomics¡±) announced that it had completed a 300 million CNY B+ round of financing.2022-06-10View More
-
-
Thermo Fisher Scientific said on Thursday that the US Food and Drug Administration has cleared its Thermo Scientific EliA RNA Pol III and EliA Rib-P tests for aiding in the diagnosis of systemic sclerosis (SSc) and systemic lupus erythematosus (SLE).2022-06-10View More
-
-
Roche subsidiary Foundation Medicine announced on Thursday that its FoundationOne CDx test has been approved by the US Food and Drug Administration as a companion diagnostic with Roche's Rozlytrek (entrectinib).2022-06-10View More
-
-
Recently, MGI and Singapore biotechnology company MiRXES Pte Ltd. (MiRXES) officially reached a strategic partnership.2022-06-09View More
-
-
LumiraDx said on Wednesday that it has received CE marking for a molecular SARS-CoV-2 test and an assay that tests for both SARS-CoV-2 and influenza virus.2022-06-09View More
-
-
Becton Dickinson and CerTest Biotec will collaborate to develop an RT-PCR-based diagnostic test for monkeypox to run on the BD Max System, they announced on Wednesday.2022-06-09View More
-
-
R-Biopharm said on Tuesday that it has acquired AusDiagnostics, an Australian maker of multiplexing molecular diagnostic assays and reagents.2022-06-08View More
-
-
The US Food and Drug Administration last week granted DxLab Emergency Use Authorization for its molecular DxLab COVID-19 test.2022-06-08View More
-
-
The Construction of Mindray, Biotime and Nanomicro R&D Bases Begins2022-06-08View More
-
-
Recently, Fosun Pharma is planning to incorporate OncoCare, one of the largest private oncology medical centers in Singapore.2022-06-07View More
-
-
By the year 2030, pancreatic cancer is expected to become the second most common cause of cancer deaths for both men and women in the United States, according to recent reports. While considered uncommon, inherited gene mutations can increase a person¡¯s risk of developing pancreatic cancer.2022-06-07View More
-
-
Pfizer Inc. announced today that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment.2022-06-07View More
-
-
GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced a broad strategic collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize companion diagnostic (CDx) assays for use with AstraZeneca¡¯s therapies.2022-06-06View More
-
-
The US Food and Drug Administration this week granted Emergency Use Authorization for LG Chem's AdvanSure SARS-CoV-2 IgG(RBD) ELISA COVID-19 antibody test.2022-06-06View More
-
-
Thermo Fisher Scientific and Qatar Genome Program, a member of the Qatar Foundation, have announced a partnership to use custom genotyping arrays to accelerate genomic research and the clinical applications of predictive genomics in Qatar.2022-06-06View More
-
-
Suzhou Bangqi Biotechnology Co., Ltd.£¨translated from company¡¯s Chinese name£© completed tens of millions of yuan in Series A financing, laying out the field of self-free & allergy diagnosis2022-06-06View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.